ISM5411

· InSilico Medicine Hong Kong Limited

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for ISM5411, covering 2024-11-07 to 2026-03-31. Get the full timeline:

Most recent: Clinical Trial Update: Study Evaluating ISM5411 Administered Orally to Subjects With Active Ulcerative Colitis (BETHESDA) [Phase 2]